Cytek Biosciences Executive and Leadership Team

Wenbin Jiang, the Chief Executive Officer & Chairman at Cytek Biosciences, directs the overarching corporate strategy and long-term vision for the organization. By overseeing the development of Full Spectrum Profiling technology, the Chief Executive Officer & Chairman ensures the company maintains a competitive edge in the biotechnology sector. Jiang manages high-level interactions with the Board to align operational goals with market demands across North America, Europe, and Asia. This leadership role involves scaling the Aurora and Northern Lights systems to meet the evolving needs of global research laboratories. Through rigorous oversight of product innovation and market expansion, Wenbin Jiang drives the company toward sustained growth. The Chief Executive Officer & Chairman prioritizes the integration of advanced cell analysis tools into clinical and research workflows, ultimately securing the firm's position as a leader in scientific research services.

William McCombe, the Chief Financial Officer at Cytek Biosciences, manages the fiscal health and capital allocation strategies required to support global operations. The Chief Financial Officer oversees financial planning, reporting, and investor relations to ensure transparency and growth. By analyzing market trends in the biotechnology sector, McCombe optimizes resource distribution for the research and development of cell analysis instruments. This role involves coordinating with the executive team to fund the expansion of distribution channels across international markets. William McCombe maintains strict adherence to financial regulations while driving efficiency in the procurement and supply chain processes for reagents and hardware. Through disciplined fiscal management, the Chief Financial Officer supports the company's mission to provide high-sensitivity tools to scientific institutions. McCombe ensures the financial stability necessary for continuous innovation in the competitive landscape of cell analysis.

Ming Yan, the Chief Technology Officer at Cytek Biosciences, architects the technical roadmap for the company's proprietary Full Spectrum Profiling technology. The Chief Technology Officer directs the research and development teams responsible for the Aurora and Northern Lights systems, ensuring high-resolution performance for complex cell analysis. Yan oversees the integration of software and hardware components to maintain the company's reputation for high-sensitivity scientific tools. By collaborating with engineering departments, the Chief Technology Officer drives the evolution of cell sorters and supporting software platforms. Ming Yan manages the technical requirements for clinical applications, including the Northern Lights CLC system, to meet regulatory standards in international markets. This leadership role involves identifying emerging trends in biotechnology to keep the product portfolio at the forefront of scientific discovery. Yan ensures that all technological advancements align with the company's commitment to precision and reliability.

Valerie Barnett, the Chief Legal Officer at Cytek Biosciences, manages all legal affairs, intellectual property protection, and regulatory compliance across global operations. The Chief Legal Officer oversees the legal framework for the company's patented technologies, ensuring that innovations remain secure in the competitive biotechnology market. Barnett directs the compliance strategy for the Northern Lights CLC system, particularly regarding its clinical use in the European Union and China. This role involves navigating complex international regulations to facilitate the expansion of research services. Valerie Barnett provides critical guidance to the Board and executive leadership on risk management and corporate governance. By mitigating legal exposure, the Chief Legal Officer supports the company's ability to distribute advanced cell analysis tools worldwide. Barnett ensures that all business practices align with legal standards, protecting the integrity of the firm's research and development initiatives.

Connie Wedel, the Chief People Officer at Cytek Biosciences, directs the human capital strategy to attract and retain top talent in the biotechnology and scientific research sectors. The Chief People Officer oversees organizational development, talent acquisition, and employee engagement initiatives across the company's global offices. By fostering a culture of innovation, Wedel ensures that the workforce remains aligned with the mission of delivering advanced cell analysis solutions. This role involves designing professional development programs that support the technical teams working on the Aurora and Northern Lights systems. Connie Wedel manages the integration of diverse teams across North America, Europe, and Asia to maintain operational cohesion. Through effective human resources management, the Chief People Officer drives the company's ability to scale its research and development capabilities. Wedel ensures that the organizational structure supports the long-term growth and strategic objectives of the firm.